A popular diabetes drug may provide protection against skin cancers, a new study says. Metformin significantly reduces people ...

A popular diabetes drug can provide protection against skin cancers, a new study says.Metformin significantly reduces ...

R-5780, an oral immuno-oncology drug designed to activate gut-regulated immune pathways, will now be evaluated in a phase 1 ...

Regeneron Pharmaceuticals, Inc. REGN provided business and pipeline updates at the 43rd Annual J.P. Morgan Healthcare ...

Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.

The positive trial results could help Regeneron cushion the blow of its disappointing fourth-quarter sales for Eylea, which ...

Even moderate drinking of one-two drinks per day raises cancer risk, say oncologists. New data suggests link of alcohol with ...

Dr Emily Alfonsi, a skin cancer specialist, has shared five skin changes to look out for as they could be a sign of cancer - ...

Adjuvant cemiplimab prolonged DFS compared with placebo for certain patients with cutaneous squamous cell carcinoma, ...

A phase 3 study of Ameluz and RhodoLED photodynamic therapy for superficial basal cell carcinoma has reached a key milestone ...

These small modifications could be warning signs of skin cancer, a disease that affects more than 170,000 people in the UK ...

Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 35.6% in the past six months compared with the industry’s decline ...